STOCKHOLM, Sweden--(BUSINESS WIRE)--Biovitrum (STO:BVT): Strong Trend Continues in Q3: January – September: Net revenues for the period increased by 69 percent to SEK 956.3 M (567.3). Net profit for the period amounted to SEK 99.0 M (-54.0) and earnings per share amounted to SEK 2.1 (-1.0). Cash and cash equivalents and short-term investments amounted to SEK 929.4 M (1,021.4) on September 30.
